Literature DB >> 9549732

Local expression of cytokines in idiopathic inflammatory myopathies.

H Lepidi1, V Frances, D Figarella-Branger, C Bartoli, A Machado-Baeta, J F Pellissier.   

Abstract

The idiopathic inflammatory myopathies (IIM), including dermatomyositis (DM), polymyositis (PM), and inclusion body myositis (IBM), are regarded as autoimmune diseases. They are characterized by chronic lymphocytic and macrophagic infiltration in muscle tissue. Of particular importance in understanding the immune response to IIM is the specific pattern of locally produced cytokines. Frozen muscle tissues from IIM (5 DM, 3 PM, and 1 IBM) were used to investigate the cytokine responses. The RT-PCR technique was instrumental to determine the pattern of expression of pro-inflammatory (IL-1 beta, IL-6, TNF-alpha), Th1 (IFN-gamma IL-2), and Th2 (IL-4) cytokines. Immunohistochemistry was also used to localize morphologically IFN-gamma and IL-4. Our results show that pro-inflammatory cytokines and Th1 cytokines are mainly expressed in IIM. The accumulation of mononuclear inflammatory cells and the inflammatory syndrome in IIM are probably related in part to the production of pro-inflammatory cytokines. Moreover, the pattern of local cytokine expression is consistent with a Th1 immune response related to autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9549732     DOI: 10.1046/j.1365-2990.1998.00092.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  26 in total

Review 1.  Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.

Authors:  Siamak Moghadam-Kia; Rohit Aggarwal; Chester V Oddis
Journal:  Expert Rev Clin Immunol       Date:  2015-08-27       Impact factor: 4.473

2.  The inflammatory milieu in idiopathic inflammatory myositis.

Authors:  Ann M Reed; Floranne Ernste
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

3.  Does computed tomography-based muscle density predict muscle function and health-related quality of life in patients with idiopathic inflammatory myopathies?

Authors:  Laura C Cleary; Leslie J Crofford; Douglas Long; Richard Charnigo; Jody Clasey; Francesca Beaman; Kirk A Jenkins; Natasha Fraser; Archana Srinivas; Nicole Dhaon; Beatriz Y Hanaoka
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-07       Impact factor: 4.794

4.  TNF-alpha induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells.

Authors:  Christian W Keller; Claudia Fokken; Stuart G Turville; Anna Lünemann; Jens Schmidt; Christian Münz; Jan D Lünemann
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

5.  Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK.

Authors:  Hector Chinoy; Fiona Salway; Sally John; Noreen Fertig; Brian D Tait; Chester V Oddis; William E R Ollier; Robert G Cooper
Journal:  Ann Rheum Dis       Date:  2007-04-03       Impact factor: 19.103

Review 6.  Novel Therapeutic Options in Treatment of Idiopathic Inflammatory Myopathies.

Authors:  Namita A Goyal; Tahseen Mozaffar
Journal:  Curr Treat Options Neurol       Date:  2018-07-23       Impact factor: 3.598

Review 7.  Selected aspects of the current management of myositis.

Authors:  James Lilleker; Sean Murphy; Robert Cooper
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-06-19       Impact factor: 5.346

Review 8.  A critical role for immature muscle precursors in myositis.

Authors:  Anne Tournadre; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2013-03-12       Impact factor: 20.543

Review 9.  Cytokine response in inflammatory myopathies.

Authors:  Anne Tournadre; Pierre Miossec
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

Review 10.  Inflammation induced loss of skeletal muscle.

Authors:  Priya Londhe; Denis C Guttridge
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.